MedPath

Aesculap AG

🇩🇪Germany
Ownership
Subsidiary
Employees
4.9K
Market Cap
-
Website
http://www.aesculap.de

Multi-center Study to Evaluate the Safety and Efficacy of Aesculap MonoMax® for Abdominal Wall Closure

Not Applicable
Completed
Conditions
Primary Median Laparotomy
Interventions
Device: MonoMax®
First Posted Date
2007-12-13
Last Posted Date
2015-05-28
Lead Sponsor
Aesculap AG
Target Recruit Count
150
Registration Number
NCT00572507
Locations
🇩🇪

Universitaetsklinikum Heidelberg, Heidelberg, Germany

🇩🇪

St. Bonifatius-Hospital; Chirurgische Klinik, Lingen, Germany

🇩🇪

Universitaetsklinikum Giessen-Marburg, Klinik fuer Viszeral-, Thorax- und Gefaesschirurgie, Marburg, Germany

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath